Welcome to Nanjing Byabscience    HOTLINE: 800-880-8748 |
Location: Home > Products > Primary Antibodies > Polyclonal antibody

Bcl-2 (phospho Ser70) Polyclonal Antibody

Polyclonal antibody

Specification

BYab-00183

  • 50UL $180 100UL $255
  • Delivery: In Stock

Product introduction Experimental scheme Citation Related products

Product introduction>

Host
Reactiveness
Use
Molecular weight (DA)
26kD
Immunogen
The antiserum was produced against synthesized peptide derived from human BCL2 around the phosphorylation site of Ser70. AA range:36-85
Specificity
Phospho-Bcl-2 (S70) Polyclonal Antibody detects endogenous levels of Bcl-2 protein only when phosphorylated at S70.
Source
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution rate
Western Blot: 1/500 - 1/2000. ELISA: 1/40000. Not yet tested in other applications.
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration
1 mg/ml
Background
BCL2 encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.
Function
Gene Name
BCL2
Protein name
Apoptosis regulator Bcl-2
Abbreviation
Bcl-2
Other name
BCL2; Apoptosis regulator Bcl-2
Fields
Human gene ID
Human protein sequence Database
Mouse gene ID
12043
Mouse protein sequence database
Rat gene ID
24224
Rat protein sequence database
P49950
Cellular localization
Tissue expression
Storage
-20°C/1 year

Experimental scheme>

Procedure

Citation(0)>

成功添加到购物车

查看购物车 继续购物

Bcl-2 (phospho Ser70) Polyclonal Antibody

亮暗模式切换
X

Online
Service

Online Service
08:30 - 17:30

service hotline

Service
Hotline

Customer service hotline

800-880-8748
Customer service hotline

扫码

Scan
Wechat

微信二维码 Scan wechat
返回顶部 TOP